Valo Health Acquires Tara Biosystems Creating First Of Its Kind Vertically Integrated Cardiovascular Platform
Apr 05, 2022•over 3 years ago
Acquiring Company
Valo
Acquired Company
TARA Biosystems, Inc.
Description
Valo Health, LLC ("Valo"), announced today the acquisition of TARA Biosystems, Inc. ("TARA"), a New York City-based cardiovascular disease biotechnology company, creating the first of its kind vertically integrated cardiovascular drug discovery and development platform. The combination of TARA's proprietary human three-dimensional tissue engineering and cardiac disease modeling capabilities with Valo's Opal Computational PlatformTM positions Valo to transform cardiovascular disease drug discovery and development.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed